JMIR Publications

ABSTRACT

Background:

Artificial intelligence (AI) is rapidly reshaping oncology, offering advancements in clinical care and patient support. A growing area of interest is the integration of empathic AI: systems integrating clinical precision with emotional intelligence to support medical decision-making and the emotional and psychosocial well-being of patients and caregivers.

Objective:

This review aimed to explore the role of empathic AI in cancer care, with a focus on its applications in patient education, clinician support, and emotional care. It also evaluated the ethical, cultural, and implementation challenges associated with its integration into clinical practice in oncology.

Methods:

A systematic search of literature was conducted in accordance with PRISMA 2020 guidelines. Peer-reviewed articles published between January 2018 and January 2025 were identified through a search of PubMed and citation tracking. Eligible studies focused on applications of empathic AI in oncology. A total of 29 studies were included and analyzed thematically across three core clinical domains: tailored communication and education, diagnostics and care plan optimization, and emotional and psychosocial support.

Results:

Empathic AI demonstrates the potential to improve cancer care by enhancing patient education, clinical decision-making, and emotional support. Common applications include personalized education for patients and providers, support for diagnostic and therapeutic decisions, and tools designed to recognize and respond to patient distress. Several studies noted improved patient engagement and reduced clinician burden. However, concerns were identified regarding overreliance on AI systems, cultural insensitivity, and patient privacy.

Conclusions:

Empathic AI represents a promising advancement in patient-centered oncology, integrating emotional intelligence into clinical care. Its successful implementation will require careful attention to ethical, cultural, and clinical considerations to ensure equity, trust, and safety in AI-assisted cancer care.